Pavlos Msaouel: Extreme and unexpected phenotypic plasticity by RMC during EZH2 inhibition
Pavlos Msaouel, Assistant Professor of Genitourinary Medical Oncology at MD Anderson Cancer Center, shared a recent article by him and colleagues on X:
“Our latest Msaouel Lab report dissects extreme and unexpected phenotypic plasticity by Renal Medullary Carcinoma during EZH2 inhibition. Much remains to be understood about what triggers and how to counteract such ‘mimicry’/transdifferentiation mechanisms across cancers.”
“A novel case of glial transdifferentiation in renal medullary carcinoma brain metastasis“
Authors: Maria A. Gubbiotti, Ian E. McCutcheon, Priya Rao, Giannicola Genovese, Linghua Wang, Artem Tarasov, Vladislav Putintsev, Amber Berlinski, Danil Stupichev, Kirill Kriukov, Suren Davitavyan, Basim Salem, Alexander Sarachakov, Dmitry Lebedev, Michael Hensley, Alexander Bagaev, Francesca Paradiso, Vladimir Kushnarev, Gleb Khegai, Nizar M. Tannir and Pavlos Msaouel
More posts featuring Pavlos Msaouel.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023